| Authors: |
Gala RP; Vaccine Nanotechnology Laboratory, Department of Pharmaceutical Sciences, Mercer University, 3001 Mercer University Drive, Atlanta, GA, 30341, USA., Popescu C; Roquette America Inc, Geneva, IL, USA., Knipp GT; Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, 575 Stadium Mall Dr, West Lafayette, IN, 47906, USA. gknipp@purdue.edu., McCain RR; Purdue Translational Pharmacology of Bindley Biosciences, Purdue University, West Lafayette, IN, USA., Ubale RV; Vaccine Nanotechnology Laboratory, Department of Pharmaceutical Sciences, Mercer University, 3001 Mercer University Drive, Atlanta, GA, 30341, USA., Addo R; Department of Pharmaceutical Sciences, Union University School of Pharmacy, Jackson, TN, USA., Bhowmik T; Takeda Vaccine Business Unit, Bozeman, MT, USA., Kulczar CD; Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, 575 Stadium Mall Dr, West Lafayette, IN, 47906, USA., D'Souza MJ; Vaccine Nanotechnology Laboratory, Department of Pharmaceutical Sciences, Mercer University, 3001 Mercer University Drive, Atlanta, GA, 30341, USA. dsouza_mj@mercer.edu. |